These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 326664)

  • 1. Oral toxicities of Clostridium botulinum toxins in response to molecular size.
    Ohishi I; Sugii S; Sakaguchi G
    Infect Immun; 1977 Apr; 16(1):107-9. PubMed ID: 326664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral toxicities of Clostridium botulinum type A and B toxins from different strains.
    Ohishi I
    Infect Immun; 1984 Feb; 43(2):487-90. PubMed ID: 6693168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.
    Ohishi I; Sakaguchi G
    Infect Immun; 1980 May; 28(2):303-9. PubMed ID: 7399665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral toxicities of Clostridium botulinum type E toxins of different forms.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1974 Aug; 27(4):241-4. PubMed ID: 4606876
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes.
    Sugii S; Ohishi I; Sakaguchi G
    Infect Immun; 1977 Jun; 16(3):910-4. PubMed ID: 19355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicities of Clostridium botulinum type C toxins of different molecular sizes in geese.
    Ohishi I; Hayashi K; Sakaguchi G; Tokuchi M
    Infect Immun; 1981 Aug; 33(2):623-4. PubMed ID: 7275321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of Clostridium botulinum type A, B and D toxin in rotting carcasses.
    Ortiz NE; Smith GR
    Epidemiol Infect; 1994 Oct; 113(2):335-43. PubMed ID: 7925670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular construction of Clostridium botulinum type F progenitor toxin.
    Ohishi I; Sakaguchi G
    Appl Microbiol; 1975 Apr; 29(4):444-7. PubMed ID: 235882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Clostridium botulinum toxin type C beta given orally to goats.
    Fjolstad M
    Acta Vet Scand; 1973; 14(1):69-80. PubMed ID: 4580956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of Clostridium botuliunum type F progenitor toxin.
    Oishi I; Sakaguchi G
    Appl Microbiol; 1974 Dec; 28(6):923-8. PubMed ID: 4615636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the cell-wall peptidoglycan and the progenitor toxin of Clostridium botulinum type C.
    Hyun SH; Sakaguchi G
    Nihon Juigaku Zasshi; 1989 Feb; 51(1):169-76. PubMed ID: 2648051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of neutral sugars in purified type G botulinum progenitor toxin and the effects of some glycolytic enzymes on its molecular dissociation and oral toxicity.
    Nukina M; Miyata T; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):159-64. PubMed ID: 1905654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.